NCT05296759View on ClinicalTrials.gov

Botulinum Toxin Type A in Diabetic Peripheral Neuropathy

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

November 1, 2021

Study Completion Date

March 8, 2022

Conditions
Diabetic Neuropathies
Interventions
DRUG

botulinum toxin A

botulinum toxin A injection

DRUG

Gabapentin

Gabapentin oral intake

DRUG

Duloxetine

Duloxetine oral drug intake

Trial Locations (1)

Unknown

faculty of medicine Alexandria university, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER

NCT05296759 - Botulinum Toxin Type A in Diabetic Peripheral Neuropathy | Biotech Hunter | Biotech Hunter